Teva Pharmaceutical Industries LimitedTEVANYSE
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank93
3Y CAGR+53.4%
5Y CAGR+34.6%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+53.4%/yr
vs +4.0%/yr prior
5Y CAGR
+34.6%/yr
Recent acceleration
Acceleration
+49.4pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
4.4x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.58 | -2.5% |
| 2024 | 4.70 | +198.2% |
| 2023 | 1.58 | +24.1% |
| 2022 | 1.27 | +36.5% |
| 2021 | 0.93 | -10.4% |
| 2020 | 1.04 | +34.4% |
| 2019 | 0.77 | -29.0% |
| 2018 | 1.09 | -1.4% |
| 2017 | 1.10 | +5.7% |
| 2016 | 1.04 | - |